Women's health startups cannot secure insurance reimbursement due to insufficient clinical evidence

Women's health companies struggle to get their products and services covered by insurance because they lack the clinical research and real-world evidence that payers demand. This creates a catch-22: startups need revenue to fund studies, but can't generate revenue without reimbursement coverage. Current solutions fail because the evidence requirements are expensive, time-consuming, and startups lack guidance on reimbursement strategy from inception.